MET and neoplasm: Studies have demonstrated that aberrant overexpression of HGF is closely associated with poor prognosis in several types of cancer, including gastric and lung cancers (18–21), Furthermore, persistent and excessive activation of the MET/HGF signalling pathway frequently enhances the invasive and metastatic potential of tumour cells.